Meta AnalysisID 2622
表现为类似多发性硬化的髓鞘少突胶质细胞糖蛋白抗体病：文献系统评价
CRD42022363015
We perform a systematic review to investigate and chronicle the frequency of neurological manifestations, imaging findings, treatments, and outcomes from data collected on published cases and case series of Myelin Oligod
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 2622
- Evidence Id
- 11180
- Core Evidence Id
- 11180
- Source Meta Analysis Id
- 2573
- Herb2 Meta Analysis Id
- HBMA002573
- Crd Id
- CRD42022363015
- Title
- Myelin Oligodendrocyte Glycoprotein Antibody Disease Presenting Similar to Multiple Sclerosis: A Systematic Review of Literature
- Review Question
- We perform a systematic review to investigate and chronicle the frequency of neurological manifestations, imaging findings, treatments, and outcomes from data collected on published cases and case series of Myelin Oligodendrocyte Glycoprotein Antibody Disease with presentation similar to Multiple Sclerosis.
- Study Type Included
- Case report, case series of MOG antibody associated patients presenting with neurological symptoms.
- Condition Being Studied
- Here, we will review cases of Myelin Oligodendrocyte Glycoprotein Antibody Disease presenting similar to Multiple Sclerosis and describe clinical and radiological findings, treatment and outcome.
- Participant
- Inclusion criteria would include patients diagnosed with Myelin Oligodendrocyte Glycoprotein Antibody Disease who presented clinically similar to Multiple Sclerosis. Exclusion criteria would include any patient with positive Myelin Oligodendrocyte Glycoprotein Antibody but no brain or spinal cord involvement, articles written in a non-English language, and articles re-publishing a previously reported case.
- Animal
- Human Disease Modelled
- Intervention
- Inclusion criteria would include patients diagnosed with Myelin Oligodendrocyte Glycoprotein Antibody Disease who presented clinically similar to Multiple Sclerosis. Exclusion criteria would include any patient with positive Myelin Oligodendrocyte Glycoprotein Antibody but no brain or spinal cord involvement, articles written in a non-English language, and articles re-publishing a previously reported case.
- Comparator Control
- There is no comparator for this review.
- Main Outcome
- Frequency of specific symptoms, pharmacological treatment modality used. We will also include morbidity and mortality data such as frequency of progression, improvement, and death. Measures of effect Frequency and mean with a standard deviation
- Outcome Measure
- Additional Outcome
- Not applicable Measures of effect Not applicable
- Study Method
- Epidemiologic, Systematic review
- Keyword
- Autoantibodies; Humans; Multiple Sclerosis; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein
- Contact
- Rajesh Gupta, MD [email protected]
- Organisational Affiliation
- University of Texas at Houston Health and Science Center https://www.uth.edu/
- Funding Source
- Not applicable Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> Not applicable
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- United States of America
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-09-29
- Registration Date
- 2022-10-10
- Anticipated Start Date
- 2022-09-29
- Anticipated Completion Date
- 2022-10-31
- Title Cn
- 表现为类似多发性硬化的髓鞘少突胶质细胞糖蛋白抗体病：文献系统评价
- Title En
- Myelin Oligodendrocyte Glycoprotein Antibody Disease Presenting Similar to Multiple Sclerosis: A Systematic Review of Literature
- Bilingual Status
- complete